The Link Between Uveal Melanoma, Non-Hodgkin's B-Cell Lymphoma, and Wolbachia
I am still baffled that no one appears willing (in North America) to conduct a a broad range PCR screen for infection by Rickettsiales (Wolbachia genes detected in blood) before determining that a patient has uveal melanoma or non-Hodgkin's lymphoma.
We have documented proof of a patient who recovered from non-Hodgkin's lymphoma (in 2015) once his Wolbachia infection was treated. And in this case, there was no trace of the nematode worm that emits it.
Instead, we are told, "Since the causes are not understood, there is no known way of preventing this disease."
Now that the EPA is allowing MosquitoMate to release Wolbachia-infected Aedes males into the environment in 20 U.S. states, we had better take notice of the uptick in rare cancers (like uveal melanoma and non-Hodgkin's lymphoma) and demand that humans be tested for Wolbachia infections.
Because there are treatment options: azithromycin, doxycycline, minocycline, or rifampicin. Some of these, I believe, can even be taken in combination.